Although the receptor for CXCL14 is still unknown, it has been reported that CXCL14 is able to synergize with CXCL12 via allosteric modulation of CXCR4 [213], and recruit myeloid DCs to the tumor sites, where it likely promotes their maturation to sustain antitumor immunity [214]. This evidence concerns the gene CXCL12 and neoplasm.